Tavish Spargo, PA-C

Tavish Spargo practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Tavish Spargo's NPI, 1326609249, was assigned on June 21, 2019. Tavish Spargo holds California license 56957.

Tavish Spargo's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Tavish Spargo's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Tavish Spargo to 1 more hospital and 1 medical group, each named with a free account. Tavish Spargo's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Tavish Spargo practices, 2 sites in all. Vendor and product names are available with a free account.

Physician assistant is Tavish Spargo's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Tavish Spargo is licensed in California.

Dmand AI lists acute skin infection, ankle or foot injury and minor injury to a limb among the conditions Tavish Spargo treats.

CMS data shows 14 Medicare services from Tavish Spargo across 1 procedure code in 2024, all of them office visits, for 45 Medicare patients. Medicare paid $630 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 45 Medicare patients who saw Tavish Spargo in 2024. The largest group is 65 to 74, with 26 patients. 64% of them have high cholesterol, and 51% have high blood pressure. 33% are also on Medicaid. Their average risk score is 1.30, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Tavish Spargo's median patient age at 52, with 64% women.

In 2024, Tavish Spargo wrote 52 Medicare Part D claims for 31 patients. 100% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $57 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Tavish Spargo for performance year 2024, reported as part of a group. Tavish Spargo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Tavish Spargo as offering telehealth.

Dmand AI links 2 papers to Tavish Spargo in 2015. Tavish Spargo's most frequent co-authors are Michael David Mirmanesh, MD and Rahim Shiraz Nazerali, MD.

CMS Open Payments shows 1 general payment to Tavish Spargo from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Tactile Systems Technology Inc paid the most, $25.

Dmand AI lists 2 awards for Tavish Spargo.